Getting a grip on prions: Oligomers, amyloids, and pathological membrane interactions

Annual Review of Biochemistry

Volumn 78, Issue , 2009, Pages 177-204

  Caughey, Byron ^a   Baron, Gerald S ^a   Chesebro, Bruce ^a   Jeffrey, Martin ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Exosomes; Glycophosphatidylinositol anchor; Protein misfolding diseases; Tunneling nanotubes

Indexed keywords

AMYLOID; OLIGOMER; PRION PROTEIN;

HUMAN; MEMBRANE BINDING; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; VIRUS INFECTIVITY; VIRUS VIRULENCE;

ANIMALS; BRAIN; HUMANS; PRION DISEASES; PRIONS; PROTEIN FOLDING;

FUNGI; MAMMALIA;

EID: 67650747654     PISSN: 00664154     EISSN: 00664154     Source Type: Book Series    
DOI: 10.1146/annurev.biochem.78.082907.145410     Document Type: Review

References (161)

1. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-44
2. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-44
3. Castilla J, Saá P, Hetz C, Soto C. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-206
4. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104:9741-46
5. Wickner RB. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisia. Science 264:566-69
6. Chien P, Weissman JS, DePace AH. 2004. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73:617-56
7. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. 1984. Purification and structural studies of a major scrapie prion protein. Cell 38:127-34
8. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT Jr, Caughey B. 1995. Nongenetic propagation of strain-specific phenotypes of scrapie prion protein. Nature 375:698-700
9. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, et al. 1994. Cell-free formation of protease-resistant prion protein. Nature 370:471-74
10. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, LansburyPTJr, Caughey B. 1995. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie spcies barrier. Proc. Natl. Acad. Sci. USA 92:3923-27
11. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, et al. 1997. Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 388:285-88
12. Caughey B, Kocisko DA, Raymond GJ, Lansbury PT. 1995. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 2:807-17
13. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. 2005. The most infectious prion protein particles. Nature 437:257-61
14. Callahan MA, Xiong L, Caughey B. 2001. Reversibility of scrapie-associated prion protein aggregation. J. Biol. Chem. 276:28022-28
15. Gadjusek DC. 1988. Transmissible and nontransmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated configurations. J. Neuroimmunol. 20:95-110
16. Jarrett JT, Lansbury PT Jr. 1993. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-58
17. Caughey B, Raymond GJ, Kocisko DA, Lansbury PT Jr. 1997. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J. Virol. 71:4107-10
18. Hill AF, Antoniou M, Collinge J. 1999. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:11-14
19. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-76
20. Legname G, Nguyen HO, Baskakov IV, Cohen FE, DeArmond SJ, Prusiner SB. 2005. Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. USA 102:2168-73
21. Hsiao KK, Groth D, Scott M, Yang SL, Serban H, et al. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91:9126-30
22. Saborio GP, Permanne B, Soto C. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-13
23. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, et al. 2006. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc. Natl. Acad. Sci. USA 103:15818-23
24. Saá P, Castilla J, Soto C. 2006. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281:35245-52
25. Geoghegan JC,Valdes PA, Orem NR, Deleault NR,Williamson RA, et al. 2007. Selective incorporation of polyanionic molecules into hamster prions. J. Biol. Chem. 282:36341-53
26. Atarashi R,Wilham JM, Christensen L, Hughson AG, Moore RA, et al. 2008. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5:211-12
27. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, et al. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4:645-50
28. Colby DW, Zhang Q, Wang S, Groth D, Legname G, et al. 2007. Prion detection by an amyloid seeding assay. Proc. Natl. Acad. Sci. USA 104:20914-19
29. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, et al. 2005. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-39
30. Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, et al. 2008. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biol. 6:e100
31. Neuendorf E,Weber A, Saalmueller A, Schatzl H, Reifenberg K, et al. 2004. Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections. J. Biol. Chem. 279:53306-16
32. Merz PA, Somerville RA,Wisniewski HM, Iqbal K. 1981. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol. 54:63-74
33. Prusiner SB, McKinley MP, Bowman KA, Bendheim PE, Bolton DC, et al. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-58
34. Sim VL, Caughey B. 2008. Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol. Aging doi:10.1016/j.neurobiolaging.2008.02.016
35. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672-80
36. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, et al. 1993. Conversion of alpha-helices into betasheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-66
37. Caughey B, Raymond GJ, Bessen RA. 1998. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 273:32230-35
38. Spassov S, Beekes M, Naumann D. 2006. Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim. Biophys. Acta 1760:1138-49
39. Bessen RA, Marsh RF. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:7859-68
40. Somerville RA, Hamilton S, Fernie K. 2005. Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. J. Gen. Virol. 86:241-46
41. Kascsak RJ, Rubenstein R, Carp RI. 1991. Evidence for biological and structural diversity among scrapie strains. In Transmissible Spongiform Encephalopathies: Scrapie, BSE and Related Human Disorders, ed. B Chesebro, pp. 139-52. Berlin /Heidelberg: Springer-Verlag
42. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, et al. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:767-78
43. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. 1996. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383:685-90
44. Safar J, Wille H, Itri V, Groth D, Serban H, et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-65
45. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, et al. 2002. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99:3563-68
46. Govaerts C,Wille H, Prusiner SB, Cohen FE. 2004. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc. Natl. Acad. Sci. USA 101:8342-47
47. Demarco ML, Daggett V. 2004. From conversion to aggregation: protofibril formation of the prion protein. Proc. Natl. Acad. Sci. USA 101:2293-98
48. Demarco ML, Silveira J, Caughey B, Daggett V. 2006. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 45:15573-82
49. Lu X, Wintrode PL, Surewicz WK. 2007. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc. Natl. Acad. Sci. USA 104:1510-15
50. Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK. 2007. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc. Natl. Acad. Sci. USA 104:18946-51
51. Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP. 2008. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. USA 105:6284-89
52. Lim KH, Nguyen TN, Damo SM, Mazur T, Ball HL, et al. 2006. Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L). Solid State Nucl. Magn. Reson. 29:183-90
53. Baxa U, Wickner RB, Steven AC, Anderson DE, Marekov LN, et al. 2007. Characterization of betasheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 46:13149-62
54. Shewmaker F, Ross ED, Tycko R, Wickner RB. 2008. Amyloids of shuffled prion domains that form prions have a parallel in-register beta-sheet structure. Biochemistry 47:4000-7
55. Shewmaker F,Wickner RB, Tycko R. 2006. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc. Natl. Acad. Sci. USA 103:19754-59
56. Wickner RB, Dyda F, Tycko R. 2008. Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc. Natl. Acad. Sci. USA 105:2403-8
57. Krishnan R, Lindquist SL. 2005. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435:765-72
58. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, et al. 2005. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA 102:17342-47
59. Ritter C, Maddelein ML, Siemer AB, Lührs T, Ernst M, et al. 2005. Correlation of structural elements and infectivity of the HET-s prion. Nature 435:844-48
60. Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, Meier BH. 2008. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523-26
61. Toyama BH, Kelly MJ, Gross JD,Weissman JS. 2007. The structural basis of yeast prion strain variants. Nature 449:233-37
62. Tanaka M, Collins SR, Toyama BH,Weissman JS. 2006. The physical basis of how prion conformations determine strain phenotypes. Nature 442:585-89
63. Sun Y, Breydo L, Makarava N, Yang Q, Bocharova OV, Baskakov IV. 2007. Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure. J. Biol. Chem. 282:9090-97
64. Anderson M, Bocharova OV, Makarava N, Breydo L, Salnikov VV, Baskakov IV. 2006. Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol. 358:580-96
65. Nelson R, Sawaya MR, Balbirnie M, Madsen AØ, Riekel C, et al. 2005. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435:773-78
66. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. 2007. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453-57
67. Chiesa R, Harris DA. 2001. Prion diseases: What is the neurotoxic molecule? Neurobiol. Dis. 8:743-63
68. Caughey B, Raymond GJ. 1991. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase- sensitive. J. Biol. Chem. 266:18217-23
69. Caughey B, Raymond GJ, Ernst D, Race RE. 1991. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65:6597-603
70. Borchelt DR, Taraboulos A, Prusiner SB. 1992. Evidence for synthesis of scrapie prion protein in the endocytic pathway. J. Biol. Chem. 267:16188-99
71. Sc-dependent cell-free formation of protease-resistant prion protein. EMBO J. 20:377-86
72. Horonchik L, Tzaban S, Ben-Zaken O, Yedidia Y, Rouvinski A, et al. 2005. Heparan sulfate is a cellular receptor for purified infectious prions. J. Biol. Chem. 280:17062-67
73. Shaked GM, Meiner Z, Avraham I, Taraboulos A, Gabizon R. 2001. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods. J. Biol. Chem. 276:14324-28
74. Leucht C, Simoneau S, Rey C, Vana K, Rieger R, et al. 2003. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4:290-95
75. Taraboulos A, Scott M, Semenov A, Avraham D, Laszlo L, Prusiner SB. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell. Biol. 129:121-32
76. Pani A, Norfo C, Abete C, Mulas C, Putzolu M, et al. 2007. Antiprion activity of cholesterol esteri-fication modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antimicrob. Agents Chemother. 51:4141-47
77. Naslavsky N, Shmeeda H, Friedlander G, Yanai A, Futerman AH, et al. 1999. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J. Biol. Chem. 274:20763-71
78. Jeffrey M, McGovern G, Goodsir CM, González L. 2009. Strain-associated variations in abnormal PrP trafficking of sheep scrapie. Brain Pathol. 19:1-11
79. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, et al. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65:1340-51
80. Bellinger-Kawahara CG, Kempner E, Groth D, Gabizon R, Prusiner SB. 1988. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology 164:537-41
81. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. 2005. Proteaseresistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J. Biol. Chem. 280:26873-79
82. Ben-Zaken O, Tzaban S, Tal Y, Horonchik L, Esko JD, et al. 2003. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278:40041-49
83. Mabbott NA, MacPherson GG. 2006. Prions and their lethal journey to the brain. Nat. Rev. Microbiol. 4:201-11
84. Aguzzi A, Sigurdson C, Heikenwaelder M. 2008. Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3:11-40
85. Prinz M, Heikenwalder M, Junt T, Schwarz P, Glatzel M, et al. 2003. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425:957-62
86. Sisó S, Jeffrey M, González L. 2009. Neuroinvasion in sheep TSEs: the role of the haematogenous route. Neuropathol. Appl. Neurobiol. 35:232-46
87. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, et al. 2008. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112:4739-45
88. Bartz JC, Kincaid AE, Bessen RA. 2003. Rapid prion neuroinvasion following tongue infection. J. Virol. 77:583-91
89. Magalhães AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, et al. 2005. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J. Neurosci. 25:5207-16
90. Greil CS, Vorberg IM,Ward AE, Meade-White KD, Harris DA, Priola SA. 2008. Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. Virology 379:284-93
91. Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R. 2005. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J. Biol. Chem. 280:17057-61
92. Sc but is required at an early stage for de novo prion infection of Rov cells. J. Virol. 81:10786-91
93. Gauczynski S, Nikles D, El-Gogo S, Papy-Garcia D, Rey C, et al. 2006. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 194:702-9
94. Jeffrey M, Martin S, Gonzalez L. 2003. Cell-associated variants of disease-specific prion protein immunolabelling are found in different sources of sheep transmissible spongiform encephalopathy. J. Gen. Virol. 84:1033-45
95. Baron GS, Magalhães AC, Prado MA, Caughey B. 2006. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J. Virol. 80:2106-17
96. Baron GS, Caughey B. 2003. Effect of glycosylphosphatidylinositol anchor-dependent and - independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J. Biol. Chem. 278:14883-92
97. Sc) into contiguous membranes. EMBO J. 21:1031-40
98. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J,Weissmann C. 2001. Transmission of scrapie by steel-surface-bound prions. Mol. Med. 7:679-84
99. Kanu N, Imokawa Y, Drechsel DN,Williamson RA, Birkett CR, et al. 2002. Transfer of scrapie prion infectivity by cell contact in culture. Curr. Biol. 12:523-30
100. Paquet S, Langevin C, Chapuis J, Jackson GS, Laude H, Vilette D. 2007. Efficient dissemination of prions through preferential transmission to nearby cells. J. Gen. Virol. 88:706-13
101. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, et al. 2004. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. USA 101:9683-88
102. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. 2007. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 211:582-90
103. McGovern G, Jeffrey M. 2007. Scrapie-specific pathology of sheep lymphoid tissues. PLoSONE2:e1304
104. Rustom A, Saffrich R, Markovic I,Walther P, Gerdes HH. 2004. Nanotubular highways for intercellular organelle transport. Science 303:1007-10
105. Caughey B, Baron GS. 2006. Prions and their partners in crime. Nature 443:803-10
106. Gerdes HH, Carvalho RN. 2008. Intercellular transfer mediated by tunneling nanotubes. Curr. Opin. Cell Biol. 20:470-75
107. ShererNM,Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, MothesW. 2007. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9:310-15
108. Leblanc P, Alais S, Porto-Carreiro I, Lehmann S, Grassi J, et al. 2006. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J. 25:2674-85
109. Caughey B, Lansbury PT. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26:267-98
110. Walsh DM, Selkoe DJ. 2007. Aβ oligomers-a decade of discovery. J. Neurochem. 101:1172-84
111. Jeffrey M, Goodsir CM, Bruce ME,McBride PA, Farquhar C. 1994. Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropathol. Appl. Neurobiol. 20:535-42
112. Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, et al. 2008. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 28:4283-92
113. Belichenko PV, Brown D, Jeffrey M, Fraser JR. 2000. Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice. Neuropathol. Appl. Neurobiol. 26:143-49
114. Jeffrey M, Goodsir CM, Race RE, Chesebro B. 2004. Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann. Neurol. 55:781-92
115. Liberski P. 2008. The tubulovesicular structures-the ultrastructural hallmark for all prion diseases. Acta Neurobiol. Exp. 68:113-21
116. Eberl H, Tittmann P, Glockshuber R. 2004. Characterization of recombinant, membrane-attached full-length prion protein. J. Biol. Chem. 279:25058-65
117. Hicks MR, Gill AC, Bath IK, Rullay AK, Sylvester ID, et al. 2006. Synthesis and structural characterization of a mimetic membrane-anchored prion protein. FEBS J. 273:1285-99
118. Elfrink K, Ollesch J, Stohr J,Willbold D, Riesner D, Gerwert K. 2008. Structural changes of membraneanchored native PrP(C). Proc. Natl. Acad. Sci. USA 105:10815-19
119. Morillas M, Swietnicki W, Gambetti P, Surewicz WK. 1999. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274:36859-65
120. Bahadi R, Farrelly PV, Kenna BL, Kourie JI, Tagliavini F, et al. 2003. Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients. Am. J. Physiol. Cell Physiol. 285:C862-72
121. Wang X,Wang F, Arterburn L,Wollmann R, Ma J. 2006. The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity. J. Biol. Chem. 281:13559-65
122. Wang F, Yang F, Hu Y, Wang X, Wang X, et al. 2007. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. Biochemistry 46:7045-53
123. Kazlauskaite J, Sanghera N, Sylvester I, Venien-Bryan C, Pinheiro TJ. 2003. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42:3295-304
124. Sanghera N, Pinheiro TJ. 2002. Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315:1241-56
125. Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, et al. 2007. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog. 3:e125
126. Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. 1990. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29:8879-84
127. Caughey B. 2001. Interactions between prion protein isoforms: The kiss of death? Trends Biochem. Sci. 26:235-42
128. Wegmann S, Miesbauer M,Winklhofer KF, Tatzelt J, Muller DJ. 2008. Observing fibrillar assemblies on scrapie-infected cells. Pflugers Arch. 456:83-93
129. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, et al. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-82
130. Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, et al. 2002. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21:202-10
131. Li A, Piccardo P, Barmada SJ, Ghetti B, Harris DA. 2007. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. EMBO J. 26:2777-85
132. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, et al. 1996. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-43
133. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. 2003. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302:871-74
134. Race R, Oldstone M, Chesebro B. 2000. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74:828-33
135. Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, et al. 1997. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16:6057-65
136. Marella M, Gaggioli C, Batoz M, Deckert M, Tartare-Deckert S, Chabry J. 2005. Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment. J. Biol. Chem. 280:1529-34
137. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:449-57
138. Harris DA, True HL. 2006. New insights into prion structure and toxicity. Neuron 50:353-57
139. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. 2008. Physiology of the prion protein. Physiol. Rev. 88:673-728
140. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, et al. 2004. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514-16
141. Watts JC, Westaway D. 2007. The prion protein family: diversity, rivalry, and dysfunction. Biochim. Biophys. Acta 1772:654-72
142. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, et al. 2007. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell 26:175-88
143. Fowler DM, Koulov AV, Balch WE, Kelly JW. 2007. Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32:217-24
144. Chiti F, Dobson CM. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75:333-66
145. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T. 2007. Prions of fungi: inherited structures and biological roles. Nat. Rev. Microbiol. 5:611-18
146. Derkatch IL, Bradley ME, Hong JY, Liebman SW. 2001. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106:171-82
147. Coustou-Linares V, Maddelein ML, Begueret J, Saupe SJ. 2001. In vivo aggregation of the HET-s prion protein of the fungus Podospora anserina. Mol. Microbiol. 42:1325-35
148. Roberts BT, Wickner RB. 2003. A class of prions that propagate via covalent auto-activation. Genes Dev. 17:2083-87
149. Kicka S, Bonnet C, Sobering AK, Ganesan LP, Silar P. 2006. A mitotically inheritable unit containing a MAP kinase module. Proc. Natl. Acad. Sci. USA 103:13445-50
150. Kisilevsky R. 2005. Preparation and propagation of amyloid-enhancing factor. Methods Mol. Biol. 299:237-41
151. Lundmark K,Westermark GT, Nystrom S, Murphy CL, Solomon A,Westermark P. 2002. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99:6979-84
152. Papendick RE, Munson L, O'Brien TD, Johnson KH. 1997. Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Vet. Pathol. 34:549-56
153. Munson L,Terio KA,Worley M, Jago M, Bagot-Smith A, Marker L. 2005. Extrinsic factors significantly affect patterns of disease in free-ranging and captive cheetah (Acinonyx jubatus) populations. J. Wildl. Dis. 41:542-48
154. Zhang B, Une Y, Fu X, Yan J, Ge F, et al. 2008. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl. Acad. Sci. USA 105:7263-68
155. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, et al. 2001. Transmission of mouse senile amyloidosis. Lab. Investig. 81:493-99
156. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, et al. 2006. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781-84
157. Si K, Lindquist S, Kandel ER. 2003. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115:879-91
158. Walker LC, LeVine H III, Mattson MP, Jucker M. 2006. Inducible proteopathies. Trends Neurosci. 29:438-43
159. Lee KS, Caughey B. 2007. A simplified recipe for prions. Proc. Natl. Acad. Sci. USA 104:9551-52
160. Ma J, Wollmann R, Lindquist S. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-85
161. Kristiansen M, Messenger MJ, Klohn PC, Brandner S, Wadsworth JD, et al. 2005. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J. Biol. Chem. 280:38851-61